Cambridge, MA
Biobot Analytics is an American biotechnology company that specializes in wastewater-based epidemiology headquartered in Cambridge, Massachusetts. The company analyzes wastewater samples to measure the concentration of various substances, including pathogens, illicit drugs, and other public health indicators. Biobot was founded in 2017 at MIT by computational biologist Mariana Matus and architect Newsha Ghaeli.
biobot.ioThese are collections Biobot Analytics is a part of. Click on the collection name to view similar companies.
Series A
$13,400,000
Series A
$20,833,737
Seed
$4,200,000
Seed
$2,500,000
Pre Seed
$120,000
Pre Seed
$345,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Biobot Analytics.